In cancer, midnolin is needed to adapt to abundant cancer‐related stress, such as oncogene activation, hypoxia, nutrient deprivation, acidosis, high‐demand secretion, metabolite deposition, and endoplasmic reticulum stress. Here, MIDN is linked to cancer.